Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Pharmaceutical giants are turning to a new method to address high prices: refund some money to insurers if a treatment doesn't work as expected, reports Bloomberg.
California Assembly member Jim Wood, D-Healdsburg, seeks to ban drugmakers from issuing coupons that lower patients' prescription copayments for certain drugs, reports California Healthline.
New data from the U.S. Bureau of Labor Statistics shows the logistics and transportation sector lost 4,000 jobs last month.
Resource Optimization & Innovation, a provider-owned supply chain services company in St. Louis, entered a contract agreement with Minneapolis-based Vertebral Technologies.
Emily Maynard Johnson, former contestant on ABC's "The Bachelor" and "The Bachelorette," partnered with Duchesnay USA to market the pregnancy drug Diclegis via Instagram, reports MM&M.
Express Scripts — the largest pharmacy benefit manager in the U.S. — released its 2016 Drug Trend Report showing prescription drug spending slowed for its members last year.
Global Healthcare Exchange, a company focused on healthcare supply chain management solutions, has rebranded Hap-X, the e-payables company it acquired in June 2016, to GHX ePay.
U.S. Rep. Greg Walden (R-Ore.) vows to advocate for legislation aiming to curb drug prices through the development of more generic drugs, reports The Wall Street Journal.
Amgen's cholesterol drug Repatha proved effective at lowering the risk of heart attacks, strokes and death in patients with heart disease in a recent clinical trial, reports Reuters.
Cambridge, Mass.-based Biogen received a subpoena on Dec. 5 from federal investigators requesting information on the price of its multiple sclerosis drugs, reports Boston Business Journal.